ADAlexis Demas

Alexis Demas

*This is an algorithmically generated author record based on publicly available information.

Alexis Demas has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    From molecular detection to historical diagnosis: interpretative challenges in paleoproteomics

    by Alexis Demas

    Paleoproteomics has become one of the most productive areas of ancient biomolecular research, with applications extending from the taxonomic identification of fragmented bone and biological sex estimation through amelogenin peptides preserved in dental enamel to the reconstruction of past cuisines, past environments, and past disease. Within this range, one class of inference carries a distinctive burden: the attribution of a cause of death to a named historical individual on the basis of a recovered biomolecule. Detection establishes presence; diagnosis requires that presence be shown to be responsible. Where a recovered peptide identifies a species or a foodstuff, the inferential distance between the two is short and existing standards largely suffice. Where a recovered microbial signature is offered as the cause of a documented death, the distance is considerable, and the framework that would license the step has not been articulated -the more so as paleoproteomics, unlike paleogenomics, has no consolidated authentication guidelines. Two recent studies of illustrious remains illustrate the problem concretely: in each, a technically accomplished analysis yielded an organism whose known clinical behaviour is difficult to reconcile with the documented terminal course, and in each an alternative etiology remains at least as compatible with the historical record. These cases do not indict the method. They delimit the class of claim it can presently sustain, and they indicate that the decisive constraint on retrospective diagnosis is clinical coherence rather than analytical sensitivity. When a peptide identifies a bone fragment as ovicaprine, or a milk protein in dental calculus indicates dairy consumption, ¹ detection establishes presence, and presence is very nearly the whole of the claim; the residual questionscontamination, database bias, differential preservation between taxa -are technical, acknowledged, and increasingly well controlled. When a microorganism recovered from the remains of a named individual is proposed as the cause of that individual's death, detection is asked to establish something categorically different: not that the organism was there, but that it was responsible. Between presence and responsibility lies a gap that no gain in analytical sensitivity can close, because the gap is not analytical.Clinical medicine enforces this distinction by daily necessity. Recovering an organism from a patient establishes that the organism is present; whether it caused the illness is a separate judgement resting on the chronology of symptoms, the anatomical distribution of lesions, the tempo of the disease, the epidemiological setting, and the plausibility of the proposed mechanism. Bloodculture contaminants, colonising flora, and organisms from non-sterile sites are all detected without being diagnostic.There are nonetheless circumstances in which the two converge, and specifying them defines the boundary. When an organism is obligately pathogenic, is recovered from a normally sterile compartment, and is accompanied by a clinical picture that matches its known behaviour, the inferential distance collapses. What licenses the shortcut is the conjunction of the three conditionsnot the sensitivity of the assay. The third is the one most often neglected in retrospective work, and it is the one that does the most work: an organism recovered from a protected compartment still requires that the illness it is said to have caused resemble the illness it is known to cause.Proteins persist under conditions and across timescales that exceed those of DNA by orders of magnitude, and this is precisely their value: they open windows paleogenomics cannot.⁵ But the two fields differ in a respect bearing directly on causal claims.Ancient DNA built its authentication apparatus in response to a sustained crisis of spurious results, and that apparatus -damage patterns as authenticity criteria, deamination signatures, independent replication, systematic blanks, sequencelevel contamination screening -is now a precondition of publication.Paleoproteomics has no equivalent consolidated framework: there is at present no explicit consensus on standards for data reporting, validation measures, or suitable contamination controls, and no agreed criteria by which researchers, reviewers and editors may evaluate ancient protein data. ⁵ Contaminating proteins enter from the burial environment, from excavation, from storage and curatorial handling, and from the laboratory itself. ⁵ Neither field is disqualified by this. But a diagnostic claim resting on ancient proteins currently carries less external authentication than the same claim resting on ancient DNA, which argues for restraint proportionate to the gap.Two studies published within months of each other make the problem concrete.Both are technically accomplished; neither is careless; and in both the difficulty lies at the same point.Cyphellophora europaea, and chromoblastomycosis, a chronic fungal infection primarily affecting the skin and subcutaneous tissues, was advanced as a possible cause of the death of 1715. ⁶ The identification is not in question. Its clinical interpretation is. The king's terminal course was marked by severe lower-limb pain followed by death within roughly twenty days, and the autopsy describes rapidly progressive extensive gangrene of the soft tissues with abdominal distension -a picture far more suggestive of an acute necrotizing septic process than of a chronic melanized fungal infection.Chromoblastomycosis is classically slowly progressive, confined to skin and subcutaneous tissue, and rarely disseminated. An acute bacterial necrotizing infection complicating a diabetic foot lesion, potentially with clostridial myonecrosis, accounts far better for the documented evidence. ⁷ Raphael. Proteomic analysis of bone fragments attributed to the painter yielded a signature for Nocardia niigatensis,...

  • Open Access

    Watching risk: fairness, medical supervision, and the spectator problem in the enhanced games

    by Alexis Demas

    The Enhanced Games are often presented as an ethically improved alternative to conventional anti-doping sport because they replace prohibition with transparency, athlete autonomy, and medical supervision. The inaugural event, held in Las Vegas in May 2026, complicates rather than confirms this framing: several winners competed without enhancement, the substances used by others were often undisclosed, and only one world record was set. Open enhancement therefore does not straightforwardly resolve the ethical problems of fairness or harm; it reorganizes competition around access to biomedical optimization, tolerance of pharmacological risk, and physician-enabled performance escalation. This model also raises a neglected question: the ethics of the spectator. If audiences knowingly consume performances built on deliberate pharmacological risk, the moral problem is no longer confined to the athlete's consent; it extends to the collective normalization of medically hazardous enhancement as entertainment. The Enhanced Games should therefore be assessed not because they introduce risk into an otherwise safe world of sport, but because they institutionalize enhancement-related risk as a structural feature of competition and convert that risk into spectacle, with spectators as active, differentiated participants in that conversion.

  • Open Access

    Comment - Louis XIV’s terminal illness clinical chronology favors necrotizing soft-tissue infection

    by Alexis Demas

    Louis XIV’s rapidly progressive terminal illness may be better explained by necrotizing soft-tissue infection than primary calciphylaxis. Severe distal pain, ascending gangrene, and fatal sepsis within three weeks suggest fulminant infection, plausibly arising from a diabetic foot lesion. Clinical chronology should remain central when evaluating competing retrospective clinicopathological hypotheses.

  • Rating a Grave

    by Alexis Demas